India focuses on cell therapy regulation as FDA’s Hamburg wraps up trip
As US FDA Commissioner Margaret Hamburg finishes her trip through India, the country is now shifting its focus to the regulation of stem cell and other cell therapies.
Archives for February 19, 2014
Majority of EU member states say ‘no’ to INNs for biosimilars
Most EU member states “strongly supported” the idea that biosimilars should be closely aligned with their reference products, according to a summary of the European Commission’s pharmaceutical committee meeting released Monday.
Cytovance to manufacture Pamlico Biopharma antibodies
CMO Cytovance Biologics has entered into a manufacturing agreement with Pamlico Biopharma to develop a group of three human IgG monoclonal antibodies intended for the treatment of Streptococcus pneumoniae infections.
MCW to use Transposagen's 'more flexible than ZFN' gene editing tools
Transposagen says its XTN Talen technology is more flexible than Zinc Finger Nuclease (ZFN) platforms for gene editing and creating genetically engineered cell lines.